|Complete surgical excision is essential for the management of patients with breast implant–associated anaplastic large-cell lymphoma|
MW Clemens, LJ Medeiros, CE Butler, KK Hunt, MA Fanale, S Horwitz, ...
Journal of Clinical Oncology 34 (2), 160, 2016
|Efficacy, Safety, and Biomarkers of Response to Azacitidine and Nivolumab in Relapsed/Refractory Acute Myeloid Leukemia: A Non-randomized, Open-label, Phase 2 Study.|
Cancer Discov., 2018
|Analyzing length-biased data with semiparametric transformation and accelerated failure time models|
Y Shen, J Ning, J Qin
Journal of the American Statistical Association 104 (487), 1192-1202, 2009
|Comprehensive geriatric assessment of risk factors associated with adverse outcomes and resource utilization in cancer patients undergoing abdominal surgery|
B Badgwell, J Stanley, GJ Chang, MHG Katz, HY Lin, J Ning, SV Klimberg, ...
Journal of surgical oncology 108 (3), 182-186, 2013
|Targeted hypoxia reduction restores T cell infiltration and sensitizes prostate cancer to immunotherapy|
P Jayaprakash, M Ai, A Liu, P Budhani, T Bartkowiak, J Sheng, C Ager, ...
The Journal of clinical investigation 128 (11), 5137-5149, 2018
|Malignancy‐associated hemophagocytic lymphohistiocytosis in adults: Relation to hemophagocytosis, characteristics, and outcomes|
GN Tamamyan, HM Kantarjian, J Ning, P Jain, K Sasaki, KL McClain, ...
Cancer 122 (18), 2857-2866, 2016
|The distribution of T‐cell subsets and the expression of immune checkpoint receptors and ligands in patients with newly diagnosed and relapsed acute myeloid leukemia|
P Williams, S Basu, G Garcia‐Manero, CS Hourigan, KA Oetjen, ...
Cancer 125 (9), 1470-1481, 2019
|Maximum likelihood estimations and EM algorithms with length-biased data|
J Qin, J Ning, H Liu, Y Shen
Journal of the American Statistical Association 106 (496), 1434-1449, 2011
|Clinical characteristics and outcomes of therapy-related chronic myelomonocytic leukemia|
K Takahashi, N Pemmaraju, P Strati, G Nogueras-Gonzalez, J Ning, ...
Blood 122 (16), 2807-2811, 2013
|Phase IB/II study of nivolumab in combination with azacytidine (AZA) in patients (pts) with relapsed acute myeloid leukemia (AML)|
N Daver, S Basu, G Garcia-Manero, JE Cortes, F Ravandi, EJ Jabbour, ...
Blood, The Journal of the American Society of Hematology 128 (22), 763-763, 2016
|Website usage and weight loss in a free commercial online weight loss program: retrospective cohort study|
KO Hwang, J Ning, AW Trickey, CN Sciamanna
Journal of medical Internet research 15 (1), e11, 2013
|Using short‐term response information to facilitate adaptive randomization for survival clinical trials|
X Huang, J Ning, Y Li, E Estey, JP Issa, DA Berry
Statistics in medicine 28 (12), 1680-1689, 2009
|Immunohistochemical expression of hormone receptors in melanoma of pregnant women, non-pregnant women and men|
JH Zhou, KB Kim, JN Myers, PS Fox, J Ning, RL Bassett, H Hasanein, ...
The American Journal of Dermatopathology 36 (1), 74, 2014
|Response‐adaptive randomization for clinical trials with adjustment for covariate imbalance|
J Ning, X Huang
Statistics in medicine 29 (17), 1761-1768, 2010
|Nonparametric estimation of bivariate failure time associations in the presence of a competing risk|
K Bandeen-Roche, J Ning
Biometrika 95 (1), 221-232, 2008
|Next‐generation sequencing identifies high frequency of mutations in potentially clinically actionable genes in sebaceous carcinoma|
MT Tetzlaff, RR Singh, EG Seviour, JL Curry, CW Hudgens, D Bell, ...
The Journal of pathology 240 (1), 84-95, 2016
|Buckley–James‐type estimator with right‐censored and length‐biased data|
J Ning, J Qin, Y Shen
Biometrics 67 (4), 1369-1378, 2011
|A Bayesian dose-finding design for drug combination trials with delayed toxicities|
S Liu, J Ning
Bayesian analysis 8 (3), 703, 2013
宁静， 肖婕， 缪柏其， 戴小莉， 宋昌耐
高等理科教育, 46-50, 2001
|A phase 2 study of ruxolitinib in combination with azacitidine in patients with myelofibrosis.|